Results 241 to 250 of about 53,240 (282)
Seasonal variation, heavy metal pollution indices and health risk assessment in the Esa-Odo reservoir, Nigeria. [PDF]
Ayodeji OA +6 more
europepmc +1 more source
Abstract Objectives To compare the Spondyloarthritis (SpA)-specific universal utility estimation from ASAS Health Index (U-ASAS-HI) with generic utilities and to understand the contribution of health outcomes, personal- and country-level factors to the U-ASAS-HI.
Omar-Javier Calixto +8 more
openaire +4 more sources
Within the variable course of ankylosing spondylitis (AS), peripheral arthritis, enthesitis, and involvement of other organs can add to the burden of the disease. The primary complaints of patients with spondyloarthritis (SpA) are pain, stiffness, fatigue, and limitation in activities and social participation.
Kiltz, U. +3 more
openaire +4 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Cancer Research, 2023
Abstract Study Aim: The goal of this research is to develop and validate a novel, disease-specific patient-reported outcome measure (PRO) for use in clinical monitoring and therapeutic trials in Lung Cancer (LC). Methods: LC currently accounts for the greatest number of cancer deaths worldwide, driving an increased need ...
Anika Varma +14 more
openaire +1 more source
Abstract Study Aim: The goal of this research is to develop and validate a novel, disease-specific patient-reported outcome measure (PRO) for use in clinical monitoring and therapeutic trials in Lung Cancer (LC). Methods: LC currently accounts for the greatest number of cancer deaths worldwide, driving an increased need ...
Anika Varma +14 more
openaire +1 more source
Environmental Science & Technology, 2006
To ensure selection of appropriate materials for industrial use in terms of toxicity, a procedure to estimate a health index (HI) that can be used for prioritizing less hazardous components of consumer products is described. The HI is based on the occupational exposure limits (OELs) of organic substances that compose the products.
Hidetaka, Yanagida +2 more
openaire +2 more sources
To ensure selection of appropriate materials for industrial use in terms of toxicity, a procedure to estimate a health index (HI) that can be used for prioritizing less hazardous components of consumer products is described. The HI is based on the occupational exposure limits (OELs) of organic substances that compose the products.
Hidetaka, Yanagida +2 more
openaire +2 more sources
The Limb Girdle Muscular Dystrophy Health Index (LGMD-HI)
Neuromuscular DisordersLimb girdle muscular dystrophy (LGMD) is a debilitating disease and the fourth most common muscular dystrophy. This study describes the development of the LGMD-Health Index (LGMD-HI). Participants were aged >18 years and recruited from three LGMD registries and GRASP-LGMD consortium.
Joy A. Stouffer +4 more
openaire +2 more sources
Perceptual and Motor Skills, 1989
Evolution of psychoanalytic dream theory from the topographical-conflict model resulted in the relative ascendance of manifest dream content and structure. Correspondingly, Freud's emphasis on the latent dream, disguised unconscious wish-fulfillment function, was paralleled by the development of an ego problem-solving-conflict function demonstrably ...
H, Wolowitz, T, Anderson
openaire +2 more sources
Evolution of psychoanalytic dream theory from the topographical-conflict model resulted in the relative ascendance of manifest dream content and structure. Correspondingly, Freud's emphasis on the latent dream, disguised unconscious wish-fulfillment function, was paralleled by the development of an ego problem-solving-conflict function demonstrably ...
H, Wolowitz, T, Anderson
openaire +2 more sources
Alzheimer's & Dementia, 2023
AbstractBackgroundAs therapeutic advancements are made in Alzheimer’s Disease (AD) and Mild Cognitive Impairment (MCI), it is important to have a fully validated, sensitive, and reliable disease‐specific patient‐reported outcome measure (PRO) to accurately measure changes in AD and MCI symptomatic disease burden. The U.S.
Spencer Rosero +8 more
openaire +1 more source
AbstractBackgroundAs therapeutic advancements are made in Alzheimer’s Disease (AD) and Mild Cognitive Impairment (MCI), it is important to have a fully validated, sensitive, and reliable disease‐specific patient‐reported outcome measure (PRO) to accurately measure changes in AD and MCI symptomatic disease burden. The U.S.
Spencer Rosero +8 more
openaire +1 more source
Alzheimer's & Dementia, 2023
AbstractBackgroundAs therapeutic advancements are made in the field of Alzheimer’s Disease (AD) and Mild Cognitive Impairment (MCI), it is important to have a fully validated, sensitive, and reliable, disease‐specific outcome measures that can accurately measure changes in AD and MCI symptomatic disease burden. The U.S. Food and Drug Administration has
Spencer Rosero +8 more
openaire +1 more source
AbstractBackgroundAs therapeutic advancements are made in the field of Alzheimer’s Disease (AD) and Mild Cognitive Impairment (MCI), it is important to have a fully validated, sensitive, and reliable, disease‐specific outcome measures that can accurately measure changes in AD and MCI symptomatic disease burden. The U.S. Food and Drug Administration has
Spencer Rosero +8 more
openaire +1 more source

